Carboplatin Export Market Intelligence: India's 273 Suppliers Shipping to 138 Countries — TransData Nexus 2026

Q: Who are the top carboplatin exporters from India?

The top carboplatin exporters from India are: 1. FRESENIUS KABI ONCOLOGY LIMITED — $27.5M (38.8% market share); 2. EUGIA PHARMA SPECIALITIES LIMITED — $7.0M (9.9% market share); 3. INTAS PHARMACEUTICALS LIMITED — $4.9M (6.8% market share); 4. GLAND PHARMA LIMITED — $4.3M (6.0% market share); 5. NV REMEDIES PRIVATE LIMITED — $2.9M (4.1% market share). Together they account for 65.8% of India's total carboplatin export value.

Q: What is the total export value of carboplatin from India?

The total export value of carboplatin from India is $70.9M USD, recorded across 3,637 shipment transactions from 273 active exporters to 138 destination countries. The average shipment value is $19.5K.

Q: Which countries import carboplatin from India?

India exports carboplatin to 138 countries worldwide. The top importing countries are: GERMANY (22.6% share, $16.0M), UNITED STATES (17.1% share, $12.2M), THAILAND (6.8% share, $4.8M), PHILIPPINES (4.6% share, $3.2M), UKRAINE (4.1% share, $2.9M). These five markets account for 55.2% of total export value.

Q: What is the HS code for carboplatin exports from India?

The primary HS code for carboplatin exports from India is 30049047. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of carboplatin exports from India?

The average unit price for carboplatin exports from India is $16.64 USD per unit, with prices ranging from $0.00 to $2205.87 depending on formulation, packaging, and order volume. The total market is valued at $70.9M across 3,637 shipments.

Q: Which ports handle carboplatin exports from India?

The primary ports for carboplatin exports from India are DELHI AIR CARGO ACC (INDEL4) (17.8% of shipments), SAHAR AIR (14.3% of shipments), SAHAR AIR CARGO ACC (INBOM4) (13.8% of shipments), DELHI AIR (12.7% of shipments), HYDERABAD AIR (3.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of carboplatin?

India is one of the world's leading exporters of carboplatin due to its large base of 273 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports carboplatin to 138 countries, demonstrating 71% global market coverage.

Q: What certifications do Indian carboplatin exporters need?

Indian carboplatin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import carboplatin from India?

There are 829 registered buyers importing carboplatin from India, spread across 138 countries. The repeat buyer rate is 63.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top carboplatin supplier from India?

FRESENIUS KABI ONCOLOGY LIMITED is the leading carboplatin exporter from India with a market share of 38.8% and total export value of $27.5M across 735 shipments. The top 5 suppliers together control 65.8% of total export value.

Suresh Sormare

Carboplatin

India Pharmaceutical Trade Intelligence

$70.9M273 Suppliers138 CountriesHS 30049047

ExportsIndia → GERMANY22.6%India → UNITED STATES17.1%

ImportsAUSTRALIA → India$1.1M SOUTH KOREA → India$89.3K

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

Carboplatin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Carboplatin to the World

Between 2022 and 2026, India exported $70.9M worth of carboplatin across 3,637 verified shipments to 138 countries — covering 71% of world markets in the Oncology segment. The largest destination is GERMANY (22.6%). FRESENIUS KABI ONCOLOGY LIMITED leads with a 38.8% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049047

Carboplatin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Carboplatin export data snapshot — $70.9M · 273 exporters · 138 countriesTransData Nexus · Indian Customs Data

Top Carboplatin Exporters from India

273 active exporters · Ranked by export value

View all 273 →

Top Carboplatin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	FRESENIUS KABI ONCOLOGY LIMITED	$27.5M	735	29	38.8%
2	EUGIA PHARMA SPECIALITIES LIMITED

Top Countries Importing Carboplatin from India

138 destination markets · Ranked by import value

All 138 countries →

Top Countries Importing Carboplatin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	GERMANY	$16.0M	22.6%
2	UNITED STATES	$12.2M	17.1%
3	THAILAND	$4.8M	6.8%
4	PHILIPPINES	$3.2M	4.6%
5	UKRAINE	$2.9M	4.1%
6	MEXICO	$2.6M	3.7%
7	COLOMBIA	$1.9M	2.7%
8	SRI LANKA	$1.9M	2.7%
9	MOROCCO	$1.6M	2.2%
10	TAIWAN	$1.6M	2.2%

GERMANY is India's largest carboplatin export destination, absorbing 22.6% of total exports worth $16.0M. The top 5 importing countries — GERMANY, UNITED STATES, THAILAND, PHILIPPINES, UKRAINE — together account for 55.2% of India's total carboplatin export value. The remaining 133 destination countries collectively receive the other 44.8%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Carboplatin to India?

13 origin countries · Total import value: $1.3M

India imports carboplatin from 13 countries with a combined import value of $1.3M. The largest supplier is AUSTRALIA ($1.1M, 14 shipments), followed by SOUTH KOREA and UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Carboplatin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	AUSTRALIA	$1.1M	14	87.5%
2	SOUTH KOREA	$89.3K	5	7.0%
3	UNITED STATES	$35.7K	9	2.8%
4	GERMANY	$19.2K	14	1.5%
5	FRANCE	$10.2K	2	0.8%
6	BELGIUM	$2.7K	2	0.2%
7	CHINA	$1.4K	1	0.1%
8	TURKEY	$530	3	0.0%
9	ITALY	$275	3	0.0%
10	THAILAND	$118	4	0.0%

Showing top 10 of 13 origin countries

AUSTRALIA is the largest supplier of carboplatin to India, accounting for 87.5% of total import value. The top 5 origin countries — AUSTRALIA, SOUTH KOREA, UNITED STATES, GERMANY, FRANCE — together supply 99.6% of India's carboplatin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Carboplatin — Export Intelligence Video

Visual overview of India's carboplatin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's carboplatin pharmaceutical import and export market — $70.9M in total trade, 273 verified manufacturers, and 138 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Carboplatin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, carboplatin is approved under multiple Abbreviated New Drug Applications (ANDAs), as listed in the FDA's Orange Book. The regulatory pathway for carboplatin involves demonstrating bioequivalence to the reference listed drug, facilitating the approval of generic versions. Given the presence of 273 active Indian exporters and 829 buyers, with a repeat buyer rate of 63.6%, the US market remains a critical destination for Indian carboplatin exports.

2EU & UK Regulatory Framework

In the European Union, carboplatin is subject to marketing authorization by the European Medicines Agency (EMA). The EMA has conducted periodic safety update report single assessments (PSUSAs) for carboplatin, with the most recent assessment completed in November 2022. These assessments ensure the continued safety and efficacy of the drug within the EU market. Compliance with EU Good Manufacturing Practice (GMP) requirements is mandatory for manufacturers exporting to the EU, ensuring product quality and safety.

3WHO Essential Medicines & Global Standards

Carboplatin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. The drug is also subject to international pharmacopoeia standards, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality across different markets.

4India Regulatory Classification

In India, carboplatin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) sets ceiling prices for essential medicines; however, specific ceiling prices for carboplatin should be verified with the latest NPPA notifications. Exporters are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of carboplatin, ensuring compliance with national regulations.

5Patent & Exclusivity Status

Carboplatin's primary patents have expired, leading to a competitive generic market. This has facilitated the entry of multiple manufacturers, including Indian exporters, into global markets. The absence of active patents allows for increased accessibility and affordability of the drug worldwide.

6Recent Industry Developments

In November 2022, the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) completed a periodic safety update report single assessment (PSUSA) for carboplatin, resulting in variations to the terms of marketing authorizations to enhance patient safety. Additionally, in January 2026, the EMA's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Zynyz, recommending its use in combination with carboplatin and paclitaxel for the first-line treatment of adult patients with metastatic or inoperable locally recurrent squamous cell carcinoma of the anal canal. These developments reflect ongoing regulatory oversight and the evolving therapeutic applications of carboplatin in combination therapies.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Carboplatin

Retail & reference prices across 9 markets vs. India FOB export price of $16.64/unit

Global Price Benchmark for Carboplatin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	Pricing information for Carboplatin is not publicly disclosed by the FDA or other U.S. government agencies.
United Kingdom	N/A	GBP	The NHS Drug Tariff does not list specific prices for Carboplatin injections.
Germany	N/A	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) does not provide public pricing information for Carboplatin.
Australia	N/A	AUD

Supply Chain Risk Assessment — Carboplatin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Carboplatin, a critical chemotherapy agent, is predominantly manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. China controls approximately 70–80% of the global KSM supply and 60–70% of the global intermediate supply, making it a global leader in this sector. This dependency exposes the supply chain to significant risks, as any disruption in China's KSM production can directly impact Carboplatin API availability.

Recent events have underscored this vulnerability. In July 2018, environmental regulations led to the shutdown of several Chinese chemical plants, causing a ripple effect that disrupted global pharmaceutical supply chains. Indian pharmaceutical companies, heavily reliant on Chinese KSMs, faced increased costs and supply uncertainties. Such incidents highlight the fragility of the current sourcing model and the need for diversification to mitigate future risks.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 reveals a high concentration among Carboplatin exporters in India. The top five exporters account for 65.8% of total exports, with FRESENIUS KABI ONCOLOGY LIMITED alone contributing 38.8% ($27.5M USD). This concentration poses a significant single-source risk; any operational or regulatory issues affecting these key players could disrupt global supply chains.

Access Complete Carboplatin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,637 transactions across 138 markets.

Request Demo View Pricing

Frequently Asked Questions — Carboplatin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top carboplatin exporters from India?

The leading carboplatin exporters from India are FRESENIUS KABI ONCOLOGY LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, INTAS PHARMACEUTICALS LIMITED, and 12 others. FRESENIUS KABI ONCOLOGY LIMITED leads with 38.8% market share ($27.5M). The top 5 suppliers together control 65.8% of total export value.

What is the total export value of carboplatin from India?

The total export value of carboplatin from India is $70.9M, recorded across 3,637 shipments from 273 active exporters to 138 countries. The average shipment value is $19.5K.

Which countries import carboplatin from India?

India exports carboplatin to 138 countries. The top importing countries are GERMANY (22.6%), UNITED STATES (17.1%), THAILAND (6.8%), PHILIPPINES (4.6%), UKRAINE (4.1%), which together account for 55.2% of total export value.

What is the HS code for carboplatin exports from India?

The primary HS code for carboplatin exports from India is 30049047. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Carboplatin

Carboplatin

Top Carboplatin Exporters from India

Top Countries Importing Carboplatin from India

Who Supplies Carboplatin to India?

Quick Facts

Related Oncology

Related Analysis

Need Details?

Carboplatin — Export Intelligence Video

Regulatory Landscape — Carboplatin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Carboplatin

Supply Chain Risk Assessment — Carboplatin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Carboplatin Trade Intelligence

Frequently Asked Questions — Carboplatin Exports from India

Who are the top carboplatin exporters from India?

What is the total export value of carboplatin from India?

Which countries import carboplatin from India?

What is the HS code for carboplatin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of carboplatin exports from India?

Which ports handle carboplatin exports from India?

Why is India a leading exporter of carboplatin?

What certifications do Indian carboplatin exporters need?

How many buyers import carboplatin from India?

What is the market share of the top carboplatin exporter from India?

Analysis Methodology